Biotech News
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
investors.soterahealth.com2026-05-06 14:45 EST
2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 2024 2025 Adjusted EBITDA (1) increased 8.2% to $594